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a longitudinal serum NMR-based 
metabolomics dataset of ischemia-
reperfusion injury in adult cardiac 
surgery
Raluca Georgiana Maltesen  1 ✉, Reinhard Wimmer  2 & Bodil Steen Rasmussen1,3
Cardiovascular disease is the leading cause of death worldwide and cardiac surgery is a key treatment. 
this study explores metabolite changes as a consequence of ischemia-reperfusion due to cardiac 
surgery with the use of cardiopulmonary bypass (CPB). to describe the ischemia-reperfusion injury, 
metabolite changes were monitored in fifty patients before and after CPB at multiple time points. 
We describe a longitudinal metabolite dataset containing nearly 600 serum nuclear magnetic 
resonance (NMR) spectra obtained from samples collected simultaneously from the pulmonary artery 
(deoxygenated blood) and left atrium (oxygenated blood) before ischemia (pre-CPB), immediately 
after reperfusion (end-CPB), and the following 2, 4, 8, and 20 hours postoperatively. In addition, a 
longitudinal dataset including 57 quantified metabolites is also provided. These datasets will help 
researchers studying ischemia-reperfusion injury, as well as the time-dependent alterations related 
to the surgical trauma and the subsequent processes required in regaining metabolite balance. the 
datasets could also be used for the development of processing algorithms for NMR-based metabolomics 
studies and methods for the analysis of longitudinal multivariate data.
Background & Summary
Cardiovascular disease is the leading cause of death in many countries1. The vast majority of cardiac patients suf-
fer from coronary artery disease, which is characterized by the build-up of cholesterol deposits in the wall of the 
coronary arteries. This leads to impaired blood flow with patients suffering chest pain and heart attacks2,3. Part of 
this population need cardiac surgery. Coronary artery bypass grafting (CABG) is considered the gold standard 
surgical procedure4, with more than one million surgeries being performed annually worldwide. Eighty percent of 
the procedures are performed with the use of a cardiopulmonary bypass (CPB) circuit4,5. CPB deprives the lungs 
of blood flow, with the lungs being solely dependent on the minimal blood supply from the bronchial arteries. 
Therefore, during CPB the lungs are at risk of experiencing ischemia. After weaning from CPB, the lungs are rep-
erfused and an ischemia-reperfusion injury can occur. The injury can further impair postoperative pulmonary 
function with the development of more severe complications such as acute respiratory distress syndrome6,7. Since 
the blood flow during CPB is non-pulsatile, other organs can be affected by ischemia-reperfusion. In a previous 
work we have shown that ischemia-reperfusion is accompanied by a series of both pulmonary and systemic 
changes and that the duration of CPB impacts not only the metabolic activity8,9, but also the fibrinolytic cascade10, 
several hours after surgery.
Shifts in the levels of lactate, citric acid cycle metabolites, purines, nicotinic acid, tyrosine, hyaluronic acid, 
ketones, fatty acids, and lipid metabolites were found to be associated with the surgical trauma and underly-
ing ischemia-reperfusion8,9. Similar alterations were observed in another recently published work involv-
ing 90 patients randomized to receive two different pulmonary protection treatments during CPB11. In 
addition, we demonstrated that prolonged surgical stress could be related to an augmented anaerobic envi-
ronment and decreased levels of fatty acids, lipids, and glycoproteins. Lastly, regaining metabolic balance after 
ischemia-reperfusion was found to be an energy and time demanding process, with few metabolites reaching 
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pre-ischemic levels the first 2–4 hours postoperatively, while imbalances in several metabolite levels were still 
observed even after 20 hours8,9,11.
In this study we present the longitudinal serum metabolite dataset obtained from 50 adults undergoing car-
diac surgery with the use of CPB. The results of this data set have been published8,9. We analysed nearly 600 
serum samples collected from the pulmonary artery (deoxygenated blood) and left atrium (oxygenated blood). 
The samples were collected just prior to CPB, immediately after CPB (0 hours), and 2, 4, 8, and 20 hours after 
CPB. Samples were measured on a nuclear magnetic resonance (NMR) spectroscopy platform and metabolite 
changes were related to the time of sample collection and duration of CPB. The data have been deposited in the 
MetaboLights repository along with the relative concentration of 57 metabolites and the time on bypass for each 
patient12.
These data are one of the first longitudinal metabolite datasets enabling the investigation of the effect of 
ischemia-reperfusion on the human metabolome. Considering the longitudinal study design and that each 
patient is its own control, this clinical dataset allows for very different utilizations. Firstly, it may assist researchers 
studying ischemia-reperfusion models and the underlying molecular mechanisms of subsequent injury. Also, it 
enables the study of the time-dependent metabolite alterations required to regain balance after surgical trauma. 
In addition, it gives the possibility to understand the possible metabolite differences elicited by oxygenating the 
blood, as we simultaneously collected deoxygenated and oxygenated blood. Moreover, data can be more broadly 
used for the development of processing algorithms for NMR-based metabolomics studies e.g. peak picking 
and deconvolution, and of statistical models for the analysis of longitudinal multivariate data. Effects of data 
pre-treatment methods such as scaling and normalization could also be investigated with regard to metabolite 
ranking from the developed models or algorithms used for biological interpretation.
Methods
All procedures described here are an expansion of the previously published material and methods8,9. A schematic 
overview of the study design, sample collection, data acquisition and analysis is provided in Fig. 1.
Patient enrolment. This study has evolved as a part of continuing efforts to understand the mechanisms 
involved in ischemia-reperfusion and to identify possible causes for the progression to postoperative complica-
tions such as acute lung injury. The study is registered at ClinicalTrials.gov (identifier: NCT02475694; title: Acute 
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Fig. 1 Schematic overview of the experimental and data analysis design. (a) A total of 50 patients were included 
in this study and standardized serum samples were obtained from the pulmonary artery (PA) and left atrium 
(LA) before cardiopulmonary bypass (Pre-CPB), at the end of CPB (Post-CPB), and at 2, 4, 8, and 20 hours 
postoperatively. (b) Samples were run on a 600 MHz nuclear magnetic resonance (NMR) spectroscopy apparat. 
(c) Processed data have been deposited at the MetaboLights database (http://www.ebi.ac.uk/metabolights) of 
the European Bioinformatics Institute under MTBLS8812. (d) NMR spectral data and metabolite quantification 
were checked by different approaches to ensure data quality. (e) Multivariate and univariate data analysis was 
performed to identify metabolite changes as a consequence of ischemia-reperfusion. Parts of the figure have 
been reprinted with permission8,9.
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Lung Injury after Cardiac Surgery: Pathogenesis) and was approved by the local Ethics Committee. This pro-
spective observational study was conducted at Aalborg University Hospital in Denmark in accordance with the 
Declaration of Helsinki. After obtaining informed written and oral consent, fifty consecutive patients scheduled 
for elective CABG with the use of CPB between September 2008 and March 2009 were included in this study. 
Inclusion criteria were adults above 18 years of age with hypercholesterolemia treated with statins, while exclusion 
criteria were patients requiring acute surgery, valve replacement, and undergoing treatment with steroids and/or 
other immune suppressor therapies. Demographics and selected data are provided in Table 1 and detailed in the 
metadata12. Additional information about the duration of anaesthesia, CABG, CPB, and ischemia-reperfusion 
are provided in the metadata.
Study design. Patients fasted overnight. The anaesthesia, surgical procedure and perfusion followed 
the institutional standardized regimens. Immediately after anaesthesia, a pulmonary artery (PA) catheter was 
inserted percutaneously in the right internal jugular vein, and after sternotomy, a left atrium (LA) catheter was 
inserted through a surgical incision in the upper right pulmonary vein. Paired blood samples were simultaneously 
collected at baseline (before CPB), immediately after weaning from CPB (0 hours), and the following 2, 4, 8, and 
20 hours postoperatively (Fig. 1a). Due to displacement of the catheters in four of the patients after 8 to 20 hours 
postoperatively, nine samples were missing from the time line. Hence, a total of 591 blood samples were collected. 
Serum was obtained through standard hospital protocols. To avoid variation, serum was separated at room tem-
perature within 30 to 40 minutes from samples collection, aliquoted, and stored at −80 °C until analysis.
NMR sample preparation and acquisition. Frozen serum samples were allowed to thaw for 30 min at 
4 °C, vortexed, and subsequently centrifuged for 5 min at 12100 g and 4 °C. A total of 400 μL of the clear superna-
tant was mixed with 200 μL 0.20 M phosphate buffer (pH 7.4, 99% 2H2O, 0.30 mM DSA-d6) in a 5 mm NMR tube. 
During the whole process samples were kept on ice.
1H NMR spectra were recorded on a BRUKER AVIII-600 MHz NMR spectrometer (BrukerBioSpin, 
Rheinstetten, Germany) equipped with a cryogenically cooled, triple-resonance CPP-TCI probe, at a temperature 
of 298.1 K (25 °C). Spectral acquisition was controlled using the TopSpin 3.1 software (Bruker BioSpin, Germany). 
T2 filtered “spin-echo Carr Purcell Meiboom and Gill” (CPMG)13 experiments with water presaturation were 
acquired with the following parameters: 65536 data points over a spectral width of 20 ppm; 256 scans; 32 dummy 
scans; a fixed receiver gain of 203; and a relaxation delay of 4 s, during which presaturation of the water resonance 
was achieved by continuous irradiation at γB1/2π = 25 Hz. T2 filtering was achieved with a repeated τ-180°-τ 
pulse sandwich with τ = 300 μs, repeated 256 times for serum samples and 128 times for plasma samples for a 
total of 80 and 40 ms, respectively.
Spectral processing. Spectral processing was carried out in TopSpin 3.1. The pre-processing steps included: 
artificial zero-filling by adding digital data points to the free induction decays to enhance spectral resolution; line 
broadening of 0.3 Hz; Fourier transformation; manual correction of spectral phase to produce pure absorption 
line shapes and to remove offsets in the peak shapes; correction of the baseline to zero; and calibration of the 
spectra to the methyl peak of L-alanine at 1.48 ppm. Spectra were reduced to buckets of 0.001 ppm width and the 
water region (4.65–4.95 ppm) was excluded using the AMIX software package (Analysis of MIXtures, v.3.9.10, 
Bruker BioSpin, Germany) (Fig. 1b). The processed metadata (Fig. 1c) is provided12.
Data analysis. Data analysis was performed in MATLAB (R2011a, MathWorks) and SPSS v.22 (IBM® 
Statistics Inc., Armonk, NY, USA). Prior to multivariate analysis, binned data were exported to MATLAB, gen-
eralized log transformed14 to enhance small signals in the spectrum, normalized to the DSA-d6 peak intensity, 
and mean centred. Data quality was checked (described in details below) prior to further analysis (Fig. 1d). 
Unsupervised principal component analysis (PCA) was applied to find the main source of variation within the 
data, to check population homogeneity, and to identify outliers based on samples’ metabolic similarities and 
dissimilarities (Fig. 1e). Partial least square (PLS) regression analysis was applied to establish metabolome associ-
ations with the duration of ischemia-reperfusion. A ten-fold Venetian-Blind cross validation was applied for val-
idation purposes. For PCA and PLS regression analysis the PLS-Toolbox 6.5 (Eigenvector Research, Wenatchee, 
WA, USA) was used. Detailed explanation for the PCA and PLS regression analysis results have been previously 
described8,9. Spectral regions contributing to sample clustering were identified and quantified. For the iden-
tification process, 1H shifts and their corresponding 13C signals were analysed by running several 2D 1H-1H 
total correlation spectroscopy (TOCSY) and 1H-13C heteronuclear single-quantum correlation (HSQC) spectra. 
Metabolite assignment was performed with the help of The Human Metabolome Database (HMDB)15, Bruker 
BBIOrefcode Database (v. 2.7.0), and literature16,17. A list of NMR chemical shifts found in TOCSY and HSQC 
spectra were reported in a previous work18. For the quantification process, peaks of interest were integrated using 
the multi-integration fitting tool implemented in the AMIX software v. 3.9.10 by using the sum of all points 
within a signal as the integration mode.
Patients n = 50
Age (years), mean ± SD 65.8 ± 9.7
Male (n) 41/50
BMI (kg/m2), mean ± SD 27.3 ± 4.0
Table 1. Characteristics of study population. The data are presented as numbers (n) or as means and standard 
deviations (SD). Abbreviation: BMI, body mass index.
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Data Records
The study is registered at ClinicalTrials.gov (https://clinicaltrials.gov/ct2/show/NCT02475694). CPMG spec-
tral data, quantified metabolites, demographic and surgical time information have been deposited at the 
MetaboLights database (http://www.ebi.ac.uk/metabolights) of the European Bioinformatics Institute under 
MTBLS88112.
technical Validation
Maintaining consistency in a sample set can be challenging, as several factors can affect the levels of metabolites. 
Studies have shown that pre-existing health conditions, diurnal variation, gender, age, diet, and exposure to stress 
factors affect the metabolome19,20. Hence, a number of precautions were taken into consideration during the sur-
gical, experimental, and data analysis procedures to ensure quality and confidence in our results.
In this study patients were relatively similar with regards to their medical history (all suffering from coronary 
artery disease), age, body mass index, and the surgical procedure. In addition, metabolite variability arising from 
diurnal effects and diet were minimized, as the surgical procedures were performed in the morning on fasting 
patients.
During sample preparation for NMR, specimens were kept on ice to avoid changes in the metabolite levels due to 
enzyme activity. The pH of the samples was measured and was found to be within a narrow range (mean ± standard 
deviation SD, 7.4 ± 0.04). To avoid changes in the metabolite levels due to longer waiting time in the NMR autosam-
pler, the number of samples chosen for each experimental procedure was at most 20 per experimental daily run. 
Also, all samples were kept at 4 °C in the autosampler before being recorded. Lastly, to avoid possible effects arising 
from variations in the NMR equipment, samples were randomly chosen for spectral acquisition.
To assure data quality, we used different strategies. First, the within-day reproducibility of NMR analysis was 
assessed. A total of 19 serum samples were run twice within an interval of 24 hours. A Pearson correlation analysis 
was performed on spectra intensities of same sample and a mean ± SD correlation coefficient of 0.992 ± 0.018 was 
found, indicating good within-day reproducibility. A representative example can be seen in Fig. 2a. Second, to 
assess the quantification accuracy of the fitted signals within a compound, two different signals arising from the 
same metabolite placed at different positions in the spectrum were compared (Fig. 1d). High fitting accuracies 
were found in all tested metabolites (Fig. 2b, Pearson correlation coefficient ≥ 0.97 with p < 0.00001), indicating 
consistent quantification. The quality of NMR measurements and metabolite quantification were further assessed 
by comparing serum glucose concentrations obtained through NMR measurements with fresh full arterial blood 
glucose measured by the standard blood gas analyser at the hospital (ABL 800 flex, Radiometer, Denmark). A 
correlation of 0.96 was obtained between both techniques (Fig. 2c) indicating high data quality. Finally, to ensure 
reliable metabolite identification, whenever necessary, additional confirmation was performed by spiking stand-
ard pure compounds into blood samples.
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Fig. 2 Data quality check. (a) For the within-day reproducibility, a blood sample collected from a patient was 
run twice, within an interval of 24 hours. High correlation is observed between two representative spectra 
of same patient (R2 = 0.9998), indicating good within-day reproducibility. Diagonal line indicates perfect 
correlation between samples. (b) The fitting accuracy of several metabolites was demonstrated by regressing two 
quantified peak areas of the same metabolite found at different regions on the NMR spectra. A good correlation 
was observed. (c) The quality of NMR measurements and of quantification accuracy was checked by comparing 
glucose concentration obtained from measuring thawed serum samples on the 600 MHz NMR with the full 
fresh arterial blood measured on the standard blood gas analyser (BGA) at the hospital. A high correlation is 
observed between instruments (Pearson correlation = 0.963, p < 0.00001). (d) Example of metabolite changes 
with time as a consequence of ischemia-reperfusion due to the use of CPB showing similarities between left 
atrial (LA) and pulmonary artery (PA) samples. Bars represent means, while error bars are 95% confidence 
intervals.
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To screen for possible outliers, a PCA was performed. No outliers were detected and the PCA scores plot 
revealed that the major variance in the data was related to ischemia-reperfusion and longitudinal serial changes 
occurring postoperatively as an attempt to regain metabolic balance. A PLS regression analysis was performed 
to link changes in the metabolome during surgery with the duration of ischemia-reperfusion8. To test which 
metabolites significantly changed as a consequence of CPB during and after surgery in both the left atrium and 
pulmonary artery samples, paired t-tests and analysis of variance (ANOVA) with Tukey’s post-hoc test for multi-
ple testing were used. Examples of representative longitudinal metabolite changes are visualised in Fig. 2d while 
additional statistical results are detailed in our previous publications8,9.
Code availability
All the pre-processing steps were performed using the available software TopSpin 3.1 (Bruker BioSpin, Germany), 
AMIX v.3.9.10 (Bruker BioSpin, Germany), and PLS-Toolbox 6.5 (Eigenvector Research, Wenatchee, WA, USA).
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